We now spend on average $2+ billion to bring a single drug to market. Can we fix Eroom's law?
General Control Founder Lada Nuzhna and Elliot Hershberg of Amplify Partners sat down with a16z's Jorge Conde for a conversation on the state of biotech. They discuss:
- How increasing regulation is making clinical trials more challenging in the US
- China's advantages in drug development
- AI's potential to help us develop drugs more efficiently
- How powerful new modalities could enable new companies to succeed
- How we could create the right economic incentives for longevity drugs
- The significance of GLP-1s to the biotech industry
And more.
Watch the episode on YouTube: https://t.co/o263W7PNQM
@ladanuzhna@ElliotHershberg@JorgeCondeBio
@ParvSondhi For orgs with heavy project funding processes this is in effect what really happens. Too often the teams ultimately responsible for delivering the solution are left out of the early stage though. If that happens, it becomes yet another game of telephone and a Frankenstein.
Love calling this out as an anti pattern. My hypothesis is that this happens mostly in companies that value and prioritize keeping the developers/engineers focused on what they do best (i.e, coding, usually to meet swag estimates). Every other player is v…https://t.co/jeLY7kAf29
According to McKinsey research, "product management capabilities are among the top two drivers of business performance for organizations across industries, according to our previous research on how software excellence fuels busines…https://t.co/zj45LxkfAg https://t.co/OuZZMEZYxP
Loved seeing this post today - we don’t talk about the pitfalls enough. I typically advise the best way to handle expectations with timelines, requests, and speaking truth to power and teams is to be very transparent, optimistic in vision but pessimistic…https://t.co/zEC3CgM3Bv
@XXfounder If their product isn’t accessible to their supposed target customers, then they’ve built a product for someone else. All manner of pig stick is delaying the inevitable slow no adoption.
I'm 36. This is my honest advice for people in their 20s:
1. Make decisions your future self will thank you for, not resent you for.
2. Somebody you know and love is going to die within the next 10 years. It could even be you. So live accordingly.
Fellow med device engineers, let me know if you're interested - this is for a dev team my Clinical Technical Product Management team works with very closely. https://t.co/FqmsvHMn9O
Calling available medical device software product owners in my network - I have another exciting opportunity open up on my team (Illumina Clinical Genomics Software & Informatics)! Please message me on LinkedIn if you are interested. #genomics#software #…https://t.co/LrrAf1jAyL
@AskCapitalOne I'm unable to connect CapitalOne 360 account to Zelle (from Zelle app - login to CapitalOne 360 brings me to generic/usual landing page with no reference to Zelle).
This tech is amazing to me! I'm not sure I'm open to implantation but I think the push for alternative therapies is the right direction. https://t.co/z70utjrtnT
@joulee I'd reorder the hypothesis sequence to learning, prioritizing, focusing...and it's probably a rinse and repeat with mastery of each skill/increase in responsibilities (for growth oriented folks). I'm currently on focusing given the challenge of distance learning and remote work.